Prosthetic Heart Valve Market
Prosthetic Heart Valves: Innovative Solutions for Improving Heart Health and Providing a New Life! Explore More with FMI!
Prosthetic Heart Valve Market by Product, End User & region - Forecast 2022 - 2032
Prosthetic Heart Valve Market Outlook (2022-2032)
[254 Pages Report] The global prosthetic heart valve market size was valued at US$ 10.9 Bn in 2021 and it is likely to touch a valuation of US$ 12.3 Bn by the end of 2022. With rising prevalence of valvular disorders such as aortic stenosis (AS), organic and ischemic (functional) mitral regurgitation, and tricuspid regurgitation, the overall demand for prosthetic valves is projected to grow at a prolific CAGR of 11.4% between 2022 and 2032, totalling US$ 36.3 Bn by 2032.
In terms of end user, the hospitals segment dominated the global prosthetic heart valve market with a total estimated revenue share of over 75% in 2021 and the trend is likely to continue during the forecast period.
|
Attribute |
Key Insights |
|
Prosthetic Heart Valve Market Estimated Value (2022) |
US$ 12.3 Bn |
|
Projected Market Value (2032) |
US$ 36.3 Bn |
|
Value-based CAGR (2022-2032) |
11.4% |
|
Market share of Top 5 countries |
62.5% |
Prosthetic heart valves are used to replace native heart valves, which poorly function or need to be replaced with an artificial heart for appropriate functioning. The purpose of an artificial valve is to function like a natural heart valve in terms of blood flow in an appropriate path in the body.
Different types of heart valves including mechanical heart valves, biological/tissue valves, and transcatheter heart valves are being used to replace native dysfunctional heart valves.
A mechanical heart valve is an artificial heart valve implanted in a patient suffering from an indicated disease such as aortic stenosis or mitral regurgitation. Tissue heart valves are the biological valves harvested from cow heart sac (bovine) or porcine (pig) heart valves mounted on a stent or used without a stent to replace a dysfunctional heart valve. A transcatheter aortic valve is designed for patients for whom conventional open heart surgery is not a safe option. It is also known as percutaneous aortic valve replacement (PAVR).
Rising cases of valvular heart diseases coupled with increasing number of heart valve replacement procedures performed worldwide is expected to boost the sales of prosthetic heart valves during the forecast period.
Similarly, development and popularity of minimally invasive procedures like transcatheter aortic valve replacement (TAVR) will further accelerate the growth of prosthetic heart valve market over the next decade.
The prosthetic heart valve market formed nearly 1% for the global cardiac assist devices market valued at approx. US$ 1,231 Bn in 2021.
Let us know your requirement to get
100% FREE customization
Development of Healthcare in the North America to Drive Prosthetic Heart Valve Market
Significant opportunities for new sales exist in developing countries throughout the North American region. As per the 2022 American College of Cardiology Foundation, the prevalence of valvular heart diseases (VHD) is rising in the United States, with more than 5 million Americans diagnosed each year, while up to 1.5 million people suffer from aortic stenosis (AS) in the United States. Approximately 500,000 of these patients suffer from severe AS.
The U.S. accounted for over 85% of the regional revenue share growing over a CAGR of 12.5%. The rise in the prevalence of disorders like diabetes and obesity are major contributing factors to the USA's dominance in this region. Also, the availability of medical expertise, new product launches and government policies are market drivers in the country.
In September 2021, Abbott reported that the United States Food and Drug Administration (USFDA) had approved the company's Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease.
Key Opportunities for Leading Prosthetic Heart Valve Market Players
The growing prevalence of heart valve disease is a significant factor driving the market's growth. Companies are also aiming to expand their market share by acquiring the local manufacturers.
Major companies in the prosthetic heart valves market comprise Medtronic, Edwards Lifesciences, Boston Scientific Corporation, On-X Life Technologies, Inc., St. Jude Medical, Inc. (Abbott), Cryolife, Inc., Micro Interventional Devices, Inc., Sorin Group, and others.
In January 2022, Artivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease, reported the publication of PROACT clinical trial results in The Annals of Thoracic Surgery, the official journal of the Society of Thoracic Surgeons. The magazine, titled Low-Dose Versus Standard Warfarin After Mechanical Mitral Valve Replacement:
A Randomized Controlled Trial, highlighted outcomes from the multicenter, non-inferiority, a two-arm study that assessed whether, after an On-X mechanical mitral valve replacement (MVR), patients could be safely managed with lower-intensity warfarin plus aspirin. The PROACT Mitral results add to the data from clinical trials that indicate that patients with On-X heart valves can be safely maintained with lower anticoagulation levels than required for competitors' mechanical valves.
Prosthetic heart valves are used to replace native heart valves, which poorly function or need to be replaced with an artificial heart for appropriate functioning. The purpose of an artificial valve is to function like a natural heart in terms of blood flow in an appropriate path in the body. The artificial hearts are implanted in a patient’s body to improve the heart valve functioning.
A mechanical heart valve is an artificial heart valve implanted in a patient suffering from an indicated disease such as aortic stenosis or mitral regurgitation. Tissue heart valves are the biological valves harvested from cow heart sac (bovine) or porcine (pig) heart valves mounted on a stent or used without a stent to replace a dysfunctional heart valve. A transcatheter aortic valve is designed for patients for whom conventional open heart surgery is not a safe option. It is also known as percutaneous aortic valve replacement (PAVR)
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystProsthetic Heart Valve Market Sales Analysis (2014-2021) Vs Demand Outlook (2022-2032)
The global sales of prosthetic heart valves are projected to rise at 11.4% CAGR between 2022 and 2032, in comparison to 11.6% CAGR registered during the historical period (2014-2021), as per Future Market Insights (FMI).
Rising incidence of cardiovascular diseases and valvular heart disorders across the world and advancement in heart valve replacement treatments are some of the key factors driving the global prosthetic heart valve market.
Similarly, growing geriatric population, rising number of cardiac interventions performed worldwide, and increased awareness of the diagnosis and treatment options for heart valve problems are likely to propel the demand for prosthetic heart valves during the forecast period.
With the rapidly evolving lifestyles of the population all over the globe, the number of various diseases and disorders has risen. One of the major disorders that can be caused by the changing lifestyle of people is cardiovascular disease. Unhealthy food, physical inactivity, cigarette consumption, and alcohol consumption are the major behavioural risk factors for heart disease and stroke.
People may experience symptoms, such as high blood pressure, high blood glucose, high blood lipids, overweight, or obesity as a result of behavioural risk factors. These risk factors are detectable in clinics or general healthcare centres and indicate a great risk of stroke, heart attack, malfunctioning of heart valves, heart failure, and other consequences. This will continue to foster the growth of prosthetic heart valve market over the next ten years.
However, high costs of such artificial devices, availability of alternative options for the treatment of heart-related issues/diseases, shortage of healthcare professionals, lack of healthcare infrastructure in lower economies, and strict government guidelines and regulations, are all limiting the growth of the global prosthetic heart valve market.
What are the Key Trends Driving the Prosthetic Heart Valve Market?
- Advancements in Prosthetic Heart Valves and Popularity of Minimally Invasive Procedures to Boost Market
In recent times, manufacturers have come up with advanced technologies which are effective, long-lasting, less invasive, and improved hemodynamic. These devices are surgically implanted in the body to replace improper/poorly functioning heart valves and come with several benefits. For instance, mechanical heart valves are extremely long-lasting and can function for up to almost 30 years in an appropriate condition.
TAVI (Transcatheter Aortic Valve Implantation), is a recently developed method for the treatment of patients suffering from aortic stenosis. In this treatment, the surgery is performed via the keyhole surgery method without even opening the chest. TAVI comes with the least complications, only 5-10% of patients may require a permanent pacemaker post-surgical treatment.
The survival of mitral valve replacement is high among the geriatric population suffering from valvular heart diseases, which is expected to increase demand for advanced prosthetic mitral valve implantation devices, thus creating lucrative opportunities for players in the market.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Which are the Factors Restraining Growth in Prosthetic Heart Valve Market?
Low diagnostic screening, poor health awareness across underdeveloped regions, and costly nature of cardiac surgeries are restraining the growth of prosthetic heart valve market.
Similarly, mechanical heart valve failure/malfunction can occur in various cases post-treatment of an artificial heart valve replacement/implantation. Though structural damage is uncommon, infections and blood clots may result in the replacement of some of them. Clots can either open or seal the mechanical valve, causing stenosis, insufficiency, or a combination of the two.
Clots can drift from the artificial valve and dislocate to the arteries and blood vessels that supply/reach the heart (coronary arteries) or the brain (carotid arteries), ultimately, resulting in a stroke or heart attack. Mechanical heart valves have a higher risk of thrombotic or thromboembolic consequences. This is emerging as a key factor expected to limit the growth of prosthetic heart valve market during the projected period.
Country Wise Insights
How Will Growth Unfold in the U.S. Prosthetic Heart Valve Market?
“Increasing Prevalence of Valvular Heart Diseases Driving Market in the U.S.”
As per FMI, the U.S. is expected to account for around 36% share in the global prosthetic heart valve market in 2022 and further expand at 12.5% CAGR during the forecast period. Rising prevalence of disorders like diabetes and obesity, increasing investments in medical research & development, and presence of favourable reimbursement policies are driving the U.S. prosthetic heart valve market.
Over the years, there has been a sharp rise in the number of valvular heart diseases across the U.S. which has necessitated the adoption of cardiac interventions like transcatheter aortic valve replacement (TAVR) and the trend is likely to continue during the forecast period.
According to the Centers for Disease Control and Prevention (CDC), around 2.5% of the U.S. population suffers from valvular heart disease, which is more common in older adults. This will continue to push the demand for prosthetic heart valves in the country during the forecast period.
Moreover, ongoing technological advancements in healthcare sector along with growing popularity of minimally invasive procedures will further generate growth prospects within the prosthetic heart valve market during the forecast period.
What Makes Germany a Prominent Prosthetic Heart Valve Market?
“Rising Number of Transcatheter Aortic Valve Replacement Fuelling Sales in Germany”
Germany accounts for around 8.8% revenue share of the global prosthetic heart valve market, making it one of the most lucrative markets across Europe. Increasing incidence of cardiac valve diseases and rising demand for minimally invasive procedures like transcatheter aortic valve replacement (TAVR) are some of the factors driving growth in Germany’s prosthetic heart valve market.
Transcatheter aortic valve replacement (TAVR) has evolved over the years as an alternative, less-invasive option for treating valvular heart diseases. Every year, around 18,000 TAVR per are performed in Germany in 97 centres using about 7 different valve types and with better reimbursement policies. Driven by this, demand for prosthetic heart valves will continue to rise at an impressive pace across the country during the forthcoming decade (2022-2032).
What is the Growth Projection for Japan’s East Asian Prosthetic Heart Valve Market?
“Surge in Geriatric Population Generating Demand in Japan”
The overall prosthetic heart valve market size in Japan reached US$ 634.5 Mn in 2021 and it is expected to grow at a CAGR of 5.8% during the forecast period. Japan faces unprecedented population ageing, and the average life expectancy is longer among the Japanese than the populations around the world. The presence of a geriatric population will boost the demand for prosthetic heart valve products in the country in the coming time as prevalence of heart disease is more among this age group.
Category Wise Insights
Which is the Highly Sought-After Product in the Global Prosthetic Heart Valve Market?
“Demand Remains High for Biological/Tissue Heart Valves in the Market”
Biological/tissue heart valves segment dominated the global prosthetic heart valve with a market share of about 42.1% in 2021 and the trend is likely to continue during the forecast period. This can be attributed to the rising popularity of biological heart valves on account of their less risk of clot formation.
Similarly, growing geriatric population and the advantages of tissue heart valves such as less risk of clot formation and least necessity of anticoagulant treatment are some factors expected to drive the prosthetic heart valves market during the forecast period.
Which is the Leading End User for Prosthetic Heart Valves?
“Most of the Prosthetic Heart Valve Sales to Remain Concentrated in Hospitals”
By end-user, hospitals segment accounted for the highest market share of about 75% in the global prosthetic heart valve market in 2021 and it is likely to retain its dominance during the forecast period.
Availability of advanced machinery, better healthcare setup, presence of trained medical expertise, and growing patient preference for opting for treatments at hospitals are some of the key factors driving growth of this segment.
Competitive Landscape
Major companies in the prosthetic heart valves market comprise Medtronic, Edwards Lifesciences, Boston Scientific Corporation, On-X Life Technologies, Inc., St. Jude Medical, Inc. (Abbott), Cryolife, Inc., Micro Interventional Devices, Inc., Sorin Group, and others.
These leading players are making high investments in the establishment of research institutes in different regions to come up with improvements in their offerings. They are adopting business strategies such as sales contracts, strategic alliances, acquiring technical expertise, new product launches and approvals, joint ventures, partnership agreements, collaborations, digital marketing, mergers and acquisitions, capacity utilisations, technological advancements etc., to gain competitive edge in the global prosthetic heart valve market. For instance,
- In 2021, Abbott got FDA approval for its Epic Plus and Epic Plus Supra Stended Tissue Valves. This approval will support the treatment of mitral and aortic valve disease.
- In 2021, Medtronic plc and Spectrum Health announced the partnership agreement to add value in healthcare and improve outcomes for spectrum health patients.
Report Scope as per Prosthetic Heart Valve Industry Analysis
|
Attribute |
Details |
|
Estimated Market Size (2022) |
US$ 12.3 Bn |
|
Projected Market Size (2032) |
US$ 36.3 Bn |
|
Anticipated Growth Rate (2022-2032) |
11.4% |
|
Forecast Period |
2022-2032 |
|
Historical Data Available for |
2014-2021 |
|
Market Analysis |
US$ Mn for Value |
|
Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa (MEA). |
|
Key Countries Covered |
USA, Canada, Brazil, Mexico, Argentina, Rest of Latin America, UK, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, Rest of Europe, Japan, China, South Korea, India, Thailand, Indonesia, Malaysia, Vietnam, Philippines, Australia, New Zealand, Turkey, GCC, South Africa, Israel, North Africa and Rest of MEA. |
|
Key Market Segments Covered |
Product, End User, Region |
|
Key Companies Profiled |
Edward Lifesciences Corporation, St. Jude Medical, Inc., Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, SYMETIS, LivaNova PLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve LLC, JenaValve Technology, Inc., Microinterventional Devices, Autotissue Berlin Gmbh, Meril Lifesciences, Comed B.V. |
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Key Market Segments Covered in Prosthetic Heart Valve Industry Research
Product:
- Mechanical Heart Valves
- Mechanical Aortic Valve
- Mechanical Mitral Valve
- Biological/Tissue Heart Valves
- Tissue Aortic Valve
- Tissue Mitral Valve
- Transcatheter Heart Valves
- Transcatheter Aortic Valve
- Transcatheter Mitral Valve
End User:
- Hospitals
- Ambulatory Services
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
The global prosthetic heart valve market is expected to reach about US$ 12.3 Bn in 2022.
As per FMI, the global prosthetic heart valve market is likely to expand at 11.4% CAGR during the forecast period (2022-2032)
The overall prosthetic heart valve market is anticipated to reach a valuation of US$ 36.3 Bn by 2032.
Hospitals segment dominated the global prosthetic heart valve market with a market share of over 75% in 2021.
The U.S., Japan, Canada, and France are the leading countries driving demand for prosthetic heart valves.
Increasing heart-related issues/disorders, advancements in new technologies and less invasive treatments, and growing geriatric population are the major factors driving the global prosthetic heart valve market.
Medtronic Public Limited Company, Edwards Lifesciences Corporation, Boston Scientific Corporation, and St. Jude Medical LLC., are the leading top players in the prosthetic heart valve market.
North America is expected to hold the highest revenue share of about US$ 5.2 Bn in the global prosthetic heart valve market by the end of 2022.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Disease Epidemiology, by Region
4.2. Key promotional strategies by manufacturers
4.3. Regulatory Landscape
4.4. Value chain analysis
4.5. Product adoption analysis
4.6. PESTEL Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Increasing Complexity of Healthcare Operations
5.2.3. Product Pricing
5.2.4. Product & Stock Availability
5.2.5. Rising Prevalence of Infections and Surgical Procedures
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. COVID19 and Impact Analysis
6.1.1. Revenue By Product
6.1.2. Revenue By End User
6.1.3. Revenue By Country
6.2. 2021 Market Scenario
7. Global Prosthetic Heart Valve Volume (Units) Analysis 2014-2021 and Forecast, 2022-2032
7.1. Historical Market Volume (Units) Analysis, 2014-2021
7.2. Current and Future Market Volume (Units) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Prosthetic Heart Valve- Pricing Analysis
8.1. Regional Pricing Analysis, by Products
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Prosthetic Heart Valve Demand (in Value or Distribution Channel in US$ Mn) Analysis 2014–2021 and Forecast, 2022–2032
9.1. Historical Market Value (US$ Mn) Analysis, 2014–2021
9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Prosthetic Heart Valve Analysis 2014–2021 and Forecast 2022–2032, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis, by Product, 2014–2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Product, 2022–2032
10.3.1. Mechanical Heart Valves
10.3.1.1. Mechanical Aortic Valve
10.3.1.2. Mechanical Mitral Valve
10.3.2. Biological/Tissue Heart Valves
10.3.2.1. Tissue Aortic Valve
10.3.2.2. Tissue Mitral Valve
10.3.3. Transcatheter Heart Valves
10.3.3.1. Transcatheter Aortic Valve
10.3.3.2. Transcatheter Mitral Valve
10.4. Market Attractiveness Analysis, by Product
11. Global Prosthetic Heart Valve Analysis 2014–2021 and Forecast 2022–2032, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis, By End User, 2014–2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by End User, 2022–2032
11.3.1. Hospitals
11.3.2. Ambulatory Services
11.4. Market Attractiveness Analysis, by End User
12. Global Prosthetic Heart Valve Analysis 2014–2021 and Forecast 2022–2032, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis, by Region, 2014–2021
12.3. Current and Future Market Value (US$ Mn) Projections, 2022–2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis, by Region
13. North America Prosthetic Heart Valve Analysis 2014–2021 and Forecast 2022–2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2014–2021
13.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2022–2032
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By End User
13.5. Market Trends
13.6. Drivers and Restraints - Impact Analysis
13.7. Country Level Analysis & Forecast
13.7.1. U.S. Prosthetic Heart Valve Analysis
13.7.1.1. Introduction
13.7.1.2. Market Analysis and Forecast, by Market Taxonomy
13.7.1.2.1. By Product
13.7.1.2.2. By End User
13.7.2. Canada Prosthetic Heart Valve Analysis
13.7.2.1. Introduction
13.7.2.2. Market Analysis and Forecast, by Market Taxonomy
13.7.2.2.1. By Product
13.7.2.2.2. By End User
14. Latin America Prosthetic Heart Valve Analysis 2014–2021 and Forecast 2022–2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2014–2021
14.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2022–2032
14.3.1. By Country
14.3.1.1. Mexico
14.3.1.2. Brazil
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By End User
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Country Level Analysis & Forecast
14.7.1. Mexico Prosthetic Heart Valve Analysis
14.7.1.1. Introduction
14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
14.7.1.2.1. By Product
14.7.1.2.2. By End User
14.7.2. Brazil Prosthetic Heart Valve Analysis
14.7.2.1. Introduction
14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
14.7.2.2.1. By Product
14.7.2.2.2. By End User
14.7.3. Argentina Prosthetic Heart Valve Analysis
14.7.3.1. Introduction
14.7.3.2. Market Analysis and Forecast, by Market Taxonomy
14.7.3.2.1. By Product
14.7.3.2.2. By End User
15. Europe Prosthetic Heart Valve Analysis 2014–2021 and Forecast 2022–2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2014–2021
15.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2022–2032
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Product
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By End User
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Country Level Analysis & Forecast
15.7.1. Germany Prosthetic Heart Valve Analysis
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
15.7.1.2.1. By Product
15.7.1.2.2. By End User
15.7.2. Italy Prosthetic Heart Valve Analysis
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
15.7.2.2.1. By Product
15.7.2.2.2. By End User
15.7.2.2.3. By Distribution Channel
15.7.3. France Prosthetic Heart Valve Analysis
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
15.7.3.2.1. By Product
15.7.3.2.2. By End User
15.7.4. U.K. Prosthetic Heart Valve Analysis
15.7.4.1. Introduction
15.7.4.2. Market Analysis and Forecast, by Market Taxonomy
15.7.4.2.1. By Product
15.7.4.2.2. By End User
15.7.5. Spain Prosthetic Heart Valve Analysis
15.7.5.1. Introduction
15.7.5.2. Market Analysis and Forecast, by Market Taxonomy
15.7.5.2.1. By Product
15.7.5.2.2. By End User
15.7.6. BENELUX Prosthetic Heart Valve Analysis
15.7.6.1. Introduction
15.7.6.2. Market Analysis and Forecast, by Market Taxonomy
15.7.6.2.1. By Product
15.7.6.2.2. By End User
15.7.7. Russia Prosthetic Heart Valve Analysis
15.7.7.1. Introduction
15.7.7.2. Market Analysis and Forecast, by Market Taxonomy
15.7.7.2.1. By Product
15.7.7.2.2. By End User
16. East Asia Prosthetic Heart Valve Analysis 2014–2021 and Forecast 2022–2032
16.1. Introduction
16.2. Historical Market Distribution Channel (US$ Mn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2014–2021
16.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2022–2032
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By End User
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Country Level Analysis & Forecast
16.7.1. China Prosthetic Heart Valve Analysis
16.7.1.1. Introduction
16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
16.7.1.2.1. By Product
16.7.1.2.2. By End User
16.7.2. Japan Prosthetic Heart Valve Analysis
16.7.2.1. Introduction
16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
16.7.2.2.1. By Product
16.7.2.2.2. By End User
16.7.3. South Korea Prosthetic Heart Valve Analysis
16.7.3.1. Introduction
16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
16.7.3.2.1. By Product
16.7.3.2.2. By End User
17. South Asia Prosthetic Heart Valve Analysis 2014–2021 and Forecast 2022–2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2014–2021
17.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2022–2032
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Indonesia
17.3.1.3. Malaysia
17.3.1.4. Thailand
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By End User
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. India Prosthetic Heart Valve Analysis
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
17.7.1.2.1. By Product
17.7.1.2.2. By End User
17.7.2. Indonesia Prosthetic Heart Valve Analysis
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
17.7.2.2.1. By Product
17.7.2.2.2. By End User
17.7.3. Malaysia Prosthetic Heart Valve Analysis
17.7.3.1. Introduction
17.7.3.2. Market Analysis and Forecast, by Market Taxonomy
17.7.3.2.1. By Product
17.7.3.2.2. By End User
17.7.4. Thailand Prosthetic Heart Valve Analysis
17.7.4.1. Introduction
17.7.4.2. Market Analysis and Forecast, by Market Taxonomy
17.7.4.2.1. By Product
17.7.4.2.2. By End User
18. Oceania Prosthetic Heart Valve2014-2021 and Forecast 2022-2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2014–2021
18.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2022–2032
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By End User
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
18.7. Country Level Analysis & Forecast
18.7.1. Australia Prosthetic Heart Valve Analysis
18.7.1.1. Introduction
18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
18.7.1.2.1. By Product
18.7.1.2.2. By End User
18.7.2. New Zealand Prosthetic Heart Valve Analysis
18.7.2.1. Introduction
18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
18.7.2.2.1. By Product
18.7.2.2.2. By End User
19. Middle East and Africa (MEA) Prosthetic Heart Valve Analysis 2014–2021 and Forecast 2022–2032
19.1. Introduction
19.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2014–2021
19.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2022–2032
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Turkey
19.3.1.3. South Africa
19.3.1.4. North Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By End User
19.5. Market Trends
19.6. Drivers and Restraints - Impact Analysis
19.7. Country Level Analysis & Forecast
19.7.1. GCC Countries Prosthetic Heart Valve Analysis
19.7.1.1. Introduction
19.7.1.2. Market Analysis and Forecast, by Market Taxonomy
19.7.1.2.1. By Product
19.7.1.2.2. By End User
19.7.2. Turkey Prosthetic Heart Valve Analysis
19.7.2.1. Introduction
19.7.2.2. Market Analysis and Forecast, by Market Taxonomy
19.7.2.2.1. By Product
19.7.2.2.2. By End User
19.7.3. South Africa Prosthetic Heart Valve Analysis
19.7.3.1. Introduction
19.7.3.2. Market Analysis and Forecast, by Market Taxonomy
19.7.3.2.1. By Product
19.7.3.2.2. By End User
19.7.4. North Africa Safety Needles Market
19.7.4.1. Introduction
19.7.4.2. Market Analysis and Forecast, by Market Taxonomy
19.7.4.2.1. By Product
19.7.4.2.2. By End User
20. Market Structure Analysis
20.1. Market Analysis, by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Medtronic Public Health Company
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Key Financials
21.3.1.4. Sales Footprint
21.3.1.5. Key Financials
21.3.1.6. SWOT Analysis
21.3.1.7. Strategy Overview
21.3.2. Edward Lifesciences Corporation,
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Key Financials
21.3.2.4. Sales Footprint
21.3.2.5. Key Financials
21.3.2.6. SWOT Analysis
21.3.2.7. Strategy Overview
21.3.3. St. Jude Medical, Inc.,
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Key Financials
21.3.3.4. Sales Footprint
21.3.3.5. Key Financials
21.3.3.6. SWOT Analysis
21.3.3.7. Strategy Overview
21.3.4. Boston Scientific Corporation,
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Key Financials
21.3.4.4. Sales Footprint
21.3.4.5. Key Financials
21.3.4.6. SWOT Analysis
21.3.4.7. Strategy Overview
21.3.5. Abbott Laboratories,
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Key Financials
21.3.5.4. Sales Footprint
21.3.5.5. Key Financials
21.3.5.6. SWOT Analysis
21.3.5.7. Strategy Overview
21.3.6. SYMETIS,
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Key Financials
21.3.6.4. Sales Footprint
21.3.6.5. Key Financials
21.3.6.6. SWOT Analysis
21.3.6.7. Strategy Overview
21.3.7. LivaNova PLC,
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Key Financials
21.3.7.4. Sales Footprint
21.3.7.5. Key Financials
21.3.7.6. SWOT Analysis
21.3.7.7. Strategy Overview
21.3.8. CryoLife, Inc.,
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Key Financials
21.3.8.4. Sales Footprint
21.3.8.5. Key Financials
21.3.8.6. SWOT Analysis
21.3.8.7. Strategy Overview
21.3.9. Braile Biomedica,
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Key Financials
21.3.9.4. Sales Footprint
21.3.9.5. Key Financials
21.3.9.6. SWOT Analysis
21.3.9.7. Strategy Overview
21.3.10. Colibri Heart Valve LLC,
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Key Financials
21.3.10.4. Sales Footprint
21.3.10.5. Key Financials
21.3.10.6. SWOT Analysis
21.3.10.7. Strategy Overview
21.3.11. JenaValve Technology, Inc.,
21.3.11.1. Overview
21.3.11.2. Product Portfolio
21.3.11.3. Key Financials
21.3.11.4. Sales Footprint
21.3.11.5. Key Financials
21.3.11.6. SWOT Analysis
21.3.11.7. Strategy Overview
21.3.12. Microinterventional Devices, ;
21.3.12.1. Overview
21.3.12.2. Product Portfolio
21.3.12.3. Key Financials
21.3.12.4. Sales Footprint
21.3.12.5. Key Financials
21.3.12.6. SWOT Analysis
21.3.12.7. Strategy Overview
21.3.13. Autotissue Berlin Gmbh,
21.3.13.1. Overview
21.3.13.2. Product Portfolio
21.3.13.3. Key Financials
21.3.13.4. Sales Footprint
21.3.13.5. Key Financials
21.3.13.6. SWOT Analysis
21.3.13.7. Strategy Overview
21.3.14. ;Meril Lifesciences,
21.3.14.1. Overview
21.3.14.2. Product Portfolio
21.3.14.3. Key Financials
21.3.14.4. Sales Footprint
21.3.14.5. Key Financials
21.3.14.6. SWOT Analysis
21.3.14.7. Strategy Overview
21.3.15. Comed B.V.
21.3.15.1. Overview
21.3.15.2. Product Portfolio
21.3.15.3. Key Financials
21.3.15.4. Sales Footprint
21.3.15.5. Key Financials
21.3.15.6. SWOT Analysis
21.3.15.7. Strategy Overview
22. Assumptions and Acronyms Used
23. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product
Table 02: Global Prosthetic Heart Valve Market Volume (Units) Analysis and Forecast 2014–2032, by Product
Table 03: Global Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by End User
Table 04: North America Prosthetic Heart Valve Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country
Table 05: North America Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product
Table 06: North America Prosthetic Heart Valve Market Volume (Units) Analysis and Forecast 2014–2032, by Product
Table 07: North America Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by End User
Table 08: Latin America Prosthetic Heart Valve Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country
Table 09: Latin America Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product
Table 10: Latin America Prosthetic Heart Valve Market Volume (Units) Analysis and Forecast 2014–2032, by Product
Table 11: Latin America Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by End User
Table 12: Europe Prosthetic Heart Valve Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country
Table 13: Europe Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product
Table 14: Europe Prosthetic Heart Valve Market Volume (Units) Analysis and Forecast 2014–2032, by Product
Table 15: Europe Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by End User
Table 16: South Asia Prosthetic Heart Valve Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country
Table 17: South Asia Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product
Table 18: South Asia Prosthetic Heart Valve Market Volume (Units) Analysis and Forecast 2014–2032, by Product
Table 19: South Asia Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by End User
Table 20: East Asia Prosthetic Heart Valve Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country
Table 21: East Asia Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product
Table 22: East Asia Prosthetic Heart Valve Market Volume (Units) Analysis and Forecast 2014–2032, by Product
Table 23: East Asia Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by End User
Table 24: Oceania Prosthetic Heart Valve Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country
Table 25: Oceania Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product
Table 26: Oceania Prosthetic Heart Valve Market Volume (Units) Analysis and Forecast 2014–2032, by Product
Table 27: Oceania Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by End User
Table 28: MEA Prosthetic Heart Valve Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country
Table 29: MEA Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product
Table 30: MEA Prosthetic Heart Valve Market Volume (Units) Analysis and Forecast 2014–2032, by Product
Table 31: MEA Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Prosthetic Heart Valve Market Volume (Units), 2014 – 2021
Figure 02: Global Prosthetic Heart Valve Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2022–2032
Figure 03: Prosthetic Heart Valve Market, Pricing Analysis per unit (US$), in 2022
Figure 04: Prosthetic Heart Valve Market, Pricing Forecast per unit (US$), in 2032
Figure 05: Global Prosthetic Heart Valve Market Value (US$ Mn) Analysis, 2014–2021
Figure 06: Global Prosthetic Heart Valve Market Forecast & Y-o-Y Growth, 2022–2032
Figure 07: Global Prosthetic Heart Valve Market Absolute $ Opportunity (US$ Mn) Analysis, 2022–2032
Figure 08: Global Prosthetic Heart Valve Market Value Share (%) Analysis 2022 and 2032, by Product
Figure 09: Global Prosthetic Heart Valve Market Y-o-Y Growth (%) Analysis 2022-2032, by Product
Figure 10: Global Prosthetic Heart Valve Market Attractiveness Analysis 2022–2032, by Product
Figure 11: Global Prosthetic Heart Valve Market Value Share (%) Analysis 2022 and 2032, by End User
Figure 12: Global Prosthetic Heart Valve Market Y-o-Y Growth (%) Analysis 2022-2032, by End User
Figure 13: Global Prosthetic Heart Valve Market Attractiveness Analysis 2022–2032, by End User
Figure 14: Global Prosthetic Heart Valve Market Value Share (%) Analysis 2022 and 2032, by Region
Figure 15: Global Prosthetic Heart Valve Market Y-o-Y Growth (%) Analysis 2022-2032, by Region
Figure 16: Global Prosthetic Heart Valve Market Attractiveness Analysis 2022–2032, by Region
Figure 17: North America Prosthetic Heart Valve Market Value (US$ Mn) Analysis, 2014–2021
Figure 18: North America Prosthetic Heart Valve Market Value (US$ Mn) Forecast, 2022-2032
Figure 19: North America Prosthetic Heart Valve Market Value Share, by Product (2022 E)
Figure 20: North America Prosthetic Heart Valve Market Value Share, by End User (2022 E)
Figure 21: North America Prosthetic Heart Valve Market Value Share, by Country (2022 E)
Figure 22: North America Prosthetic Heart Valve Market Attractiveness Analysis by Product, 2022–2032
Figure 23: North America Prosthetic Heart Valve Market Attractiveness Analysis by End User, 2022–2032
Figure 24: North America Prosthetic Heart Valve Market Attractiveness Analysis by Country, 2022–2032
Figure 25: U.S. Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 26: Global Vs. U.S. Growth Comparison, 2021 - 2032
Figure 27: U.S. Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 28: U.S. Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 29: Canada Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 30: Global Vs. Canada. Growth Comparison, 2021 - 2032
Figure 31: Canada Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 32: Canada Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 33: Latin America Prosthetic Heart Valve Market Value (US$ Mn) Analysis, 2014–2021
Figure 34: Latin America Prosthetic Heart Valve Market Value (US$ Mn) Forecast, 2022-2032
Figure 35: Latin America Prosthetic Heart Valve Market Value Share, by Product (2022 E)
Figure 36: Latin America Prosthetic Heart Valve Market Value Share, by End User (2022 E)
Figure 37: Latin America Prosthetic Heart Valve Market Value Share, by Country (2022 E)
Figure 38: Latin America Prosthetic Heart Valve Market Attractiveness Analysis by Product, 2022–2032
Figure 39: Latin America Prosthetic Heart Valve Market Attractiveness Analysis by End User, 2022–2032
Figure 40: Latin America Prosthetic Heart Valve Market Attractiveness Analysis by Country, 2022–2032
Figure 41: Mexico Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 42: Global Vs Mexico Growth Comparison, 2021 - 2032
Figure 43: Mexico Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 44: Mexico Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 45: Brazil Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 46: Global Vs. Brazil. Growth Comparison, 2021 - 2032
Figure 47: Brazil Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 48: Brazil Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 49: Argentina Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 50: Global Vs Argentina Growth Comparison, 2021 - 2032
Figure 51: Argentina Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 52: Argentina Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 53: Europe Prosthetic Heart Valve Market Value (US$ Mn) Analysis, 2014–2021
Figure 54: Europe Prosthetic Heart Valve Market Value (US$ Mn) Forecast, 2022-2032
Figure 55: Europe Prosthetic Heart Valve Market Value Share, by Product (2022 E)
Figure 56: Europe Prosthetic Heart Valve Market Value Share, by End User (2022 E)
Figure 57: Europe Prosthetic Heart Valve Market Value Share, by Country (2022 E)
Figure 58: Europe Prosthetic Heart Valve Market Attractiveness Analysis by Product, 2022–2032
Figure 59: Europe Prosthetic Heart Valve Market Attractiveness Analysis by End User, 2022–2032
Figure 60: Europe Prosthetic Heart Valve Market Attractiveness Analysis by Country, 2022–2032
Figure 61: UK Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 62: Global Vs. UK Growth Comparison, 2021 - 2032
Figure 63: UK Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 64: UK Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 65: Germany Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 66: Global Vs. Germany Growth Comparison, 2021 - 2032
Figure 67: Germany Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 68: Germany Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 69: Italy Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 70: Global Vs. Italy Growth Comparison, 2021 - 2032
Figure 71: Italy Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 72: Italy Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 73: France Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 74: Global Vs France Growth Comparison, 2021 - 2032
Figure 75: France Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 76: France Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 77: Spain Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 78: Global Vs Spain Growth Comparison, 2021 - 2032
Figure 79: Spain Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 80: Spain Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 81: Russia Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 82: Global Vs Russia Growth Comparison, 2021 - 2032
Figure 83: Russia Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 84: Russia Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 85: BENELUX Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 86: Global Vs BENELUX Growth Comparison, 2021 - 2032
Figure 87: BENELUX Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 88: BENELUX Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 89: East Asia Prosthetic Heart Valve Market Value (US$ Mn) Analysis, 2014–2021
Figure 90: East Asia Prosthetic Heart Valve Market Value (US$ Mn) Forecast, 2022-2032
Figure 91: East Asia Prosthetic Heart Valve Market Value Share, by Product (2022 E)
Figure 92: East Asia Prosthetic Heart Valve Market Value Share, by End User (2022 E)
Figure 93: East Asia Prosthetic Heart Valve Market Value Share, by Country (2022 E)
Figure 94: East Asia Prosthetic Heart Valve Market Attractiveness Analysis by Product, 2022–2032
Figure 95: East Asia Prosthetic Heart Valve Market Attractiveness Analysis by End User, 2022–2032
Figure 96: East Asia Prosthetic Heart Valve Market Attractiveness Analysis by Country, 2022–2032
Figure 97: China Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 98: Global Vs. China Growth Comparison, 2021 - 2032
Figure 99: China Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 100: China Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 101: Japan Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 102: Global Vs. Japan Growth Comparison, 2021 - 2032
Figure 103: Japan Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 104: Japan Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 105: South Korea Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 106: Global Vs South Korea Growth Comparison, 2021 - 2032
Figure 107: South Korea Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 108: South Korea Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 109: South Asia Prosthetic Heart Valve Market Value (US$ Mn) Analysis, 2014–2021
Figure 110: South Asia Prosthetic Heart Valve Market Value (US$ Mn) Forecast, 2022-2032
Figure 111: South Asia Prosthetic Heart Valve Market Value Share, by Product (2022 E)
Figure 112: South Asia Prosthetic Heart Valve Market Value Share, by End User (2022 E)
Figure 113: South Asia Prosthetic Heart Valve Market Value Share, by Country (2022 E)
Figure 114: South Asia Prosthetic Heart Valve Market Attractiveness Analysis by Product, 2022–2032
Figure 115: South Asia Prosthetic Heart Valve Market Attractiveness Analysis by End User, 2022–2032
Figure 116: South Asia Prosthetic Heart Valve Market Attractiveness Analysis by Country, 2022–2032
Figure 117: India Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 118: Global Vs. India Growth Comparison, 2021 - 2032
Figure 119: India Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 120: India Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 121: Indonesia Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 122: Global Vs. Indonesia Growth Comparison, 2021 - 2032
Figure 123: Indonesia Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 124: Indonesia Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 125: Malaysia Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 126: Global Vs. Malaysia Growth Comparison, 2021 - 2032
Figure 127: Malaysia Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 128: Malaysia Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 129: Thailand Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 130: Global Vs. Thailand Growth Comparison, 2021 - 2032
Figure 131: Thailand Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 132: Thailand Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 133: Oceania Prosthetic Heart Valve Market Value (US$ Mn) Analysis, 2014–2021
Figure 134: Oceania Prosthetic Heart Valve Market Value (US$ Mn) Forecast, 2022-2032
Figure 135: Oceania Prosthetic Heart Valve Market Value Share, by Product (2022 E)
Figure 136: Oceania Prosthetic Heart Valve Market Value Share, by End User (2022 E)
Figure 137: Oceania Prosthetic Heart Valve Market Value Share, by Country (2022 E)
Figure 138: Oceania Prosthetic Heart Valve Market Attractiveness Analysis by Product, 2022–2032
Figure 139: Oceania Prosthetic Heart Valve Market Attractiveness Analysis by End User, 2022–2032
Figure 140: Oceania Prosthetic Heart Valve Market Attractiveness Analysis by Country, 2022–2032
Figure 141: Australia Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 142: Global Vs. Australia Growth Comparison, 2021 - 2032
Figure 143: Australia Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 144: Australia Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 145: New Zealand Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 146: Global Vs New Zealand Growth Comparison, 2021 - 2032
Figure 147: New Zealand Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 148: New Zealand Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 149: Middle East & Africa Prosthetic Heart Valve Market Value (US$ Mn) Analysis, 2014–2021
Figure 150: Middle East & Africa Prosthetic Heart Valve Market Value (US$ Mn) Forecast, 2022-2032
Figure 151: Middle East & Africa Prosthetic Heart Valve Market Value Share, by Product (2022 E)
Figure 152: Middle East & Africa Prosthetic Heart Valve Market Value Share, by End User (2022 E)
Figure 153: Middle East & Africa Prosthetic Heart Valve Market Value Share, by Country (2022 E)
Figure 154: Middle East & Africa Prosthetic Heart Valve Market Attractiveness Analysis by Product, 2022–2032
Figure 155: Middle East & Africa Prosthetic Heart Valve Market Attractiveness Analysis by End User, 2022–2032
Figure 156: Middle East & Africa Prosthetic Heart Valve Market Attractiveness Analysis by Country, 2022–2032
Figure 157: GCC Countries Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 158: Global Vs GCC Countries Growth Comparison, 2021 - 2032
Figure 159: GCC Countries Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 160: GCC Countries Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 161: Turkey Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 162: Global Vs. Turkey Growth Comparison, 2021 - 2032
Figure 163: Turkey Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 164: Turkey Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 165: South Africa Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 166: Global Vs. South Africa Growth Comparison, 2021 - 2032
Figure 167: South Africa Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 168: South Africa Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Figure 169: North Africa Prosthetic Heart Valve Market Value Proportion Analysis, 2022
Figure 170: Global Vs North Africa Growth Comparison, 2021 - 2032
Figure 171: North Africa Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032
Figure 172: North Africa Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
